nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—L-DOPA—Melphalan—peripheral nervous system neoplasm	0.42	1	CrCrCtD
Epinephrine—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.0836	0.276	CbGbCtD
Epinephrine—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0458	0.151	CbGbCtD
Epinephrine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.035	0.115	CbGbCtD
Epinephrine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0293	0.0967	CbGbCtD
Epinephrine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.028	0.0923	CbGbCtD
Epinephrine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0183	0.0605	CbGbCtD
Epinephrine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.017	0.0562	CbGbCtD
Epinephrine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0137	0.0452	CbGbCtD
Epinephrine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0126	0.0414	CbGbCtD
Epinephrine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00783	0.0258	CbGbCtD
Epinephrine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00717	0.0237	CbGbCtD
Epinephrine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00489	0.0161	CbGbCtD
Epinephrine—Dipivefrin—BCHE—peripheral nervous system neoplasm	0.00191	0.536	CrCbGaD
Epinephrine—Terbutaline—BCHE—peripheral nervous system neoplasm	0.00165	0.464	CrCbGaD
Epinephrine—Renal failure—Isotretinoin—peripheral nervous system neoplasm	0.000599	0.00317	CcSEcCtD
Epinephrine—Myocardial infarction—Isotretinoin—peripheral nervous system neoplasm	0.000598	0.00316	CcSEcCtD
Epinephrine—Myocardial infarction—Tretinoin—peripheral nervous system neoplasm	0.000598	0.00316	CcSEcCtD
Epinephrine—Sweating—Topotecan—peripheral nervous system neoplasm	0.000589	0.00312	CcSEcCtD
Epinephrine—Psychotic disorder—Alitretinoin—peripheral nervous system neoplasm	0.000586	0.0031	CcSEcCtD
Epinephrine—Sweating—Tretinoin—peripheral nervous system neoplasm	0.000585	0.00309	CcSEcCtD
Epinephrine—Sweating—Isotretinoin—peripheral nervous system neoplasm	0.000585	0.00309	CcSEcCtD
Epinephrine—Haemoglobin—Topotecan—peripheral nervous system neoplasm	0.000555	0.00293	CcSEcCtD
Epinephrine—Haemorrhage—Topotecan—peripheral nervous system neoplasm	0.000552	0.00292	CcSEcCtD
Epinephrine—Haemoglobin—Isotretinoin—peripheral nervous system neoplasm	0.00055	0.00291	CcSEcCtD
Epinephrine—Haemoglobin—Tretinoin—peripheral nervous system neoplasm	0.00055	0.00291	CcSEcCtD
Epinephrine—Hypoaesthesia—Topotecan—peripheral nervous system neoplasm	0.000549	0.0029	CcSEcCtD
Epinephrine—Haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.000547	0.00289	CcSEcCtD
Epinephrine—Haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.000547	0.00289	CcSEcCtD
Epinephrine—Hypoaesthesia—Tretinoin—peripheral nervous system neoplasm	0.000545	0.00288	CcSEcCtD
Epinephrine—Hypoaesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000545	0.00288	CcSEcCtD
Epinephrine—Hallucination—Isotretinoin—peripheral nervous system neoplasm	0.000545	0.00288	CcSEcCtD
Epinephrine—Hallucination—Tretinoin—peripheral nervous system neoplasm	0.000545	0.00288	CcSEcCtD
Epinephrine—Haemoglobin—Melphalan—peripheral nervous system neoplasm	0.000543	0.00287	CcSEcCtD
Epinephrine—Haemorrhage—Melphalan—peripheral nervous system neoplasm	0.00054	0.00286	CcSEcCtD
Epinephrine—Cerebrovascular accident—Cisplatin—peripheral nervous system neoplasm	0.000521	0.00276	CcSEcCtD
Epinephrine—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.000508	0.00269	CcSEcCtD
Epinephrine—Flushing—Tretinoin—peripheral nervous system neoplasm	0.000508	0.00269	CcSEcCtD
Epinephrine—Sweating increased—Alitretinoin—peripheral nervous system neoplasm	0.000505	0.00267	CcSEcCtD
Epinephrine—Flushing—Melphalan—peripheral nervous system neoplasm	0.000501	0.00265	CcSEcCtD
Epinephrine—Arrhythmia—Tretinoin—peripheral nervous system neoplasm	0.000489	0.00259	CcSEcCtD
Epinephrine—Arrhythmia—Isotretinoin—peripheral nervous system neoplasm	0.000489	0.00259	CcSEcCtD
Epinephrine—Ventricular arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000488	0.00258	CcSEcCtD
Epinephrine—Arrhythmia—Melphalan—peripheral nervous system neoplasm	0.000483	0.00255	CcSEcCtD
Epinephrine—Mental disorder—Tretinoin—peripheral nervous system neoplasm	0.00048	0.00254	CcSEcCtD
Epinephrine—Mental disorder—Isotretinoin—peripheral nervous system neoplasm	0.00048	0.00254	CcSEcCtD
Epinephrine—Erythema—Tretinoin—peripheral nervous system neoplasm	0.000476	0.00252	CcSEcCtD
Epinephrine—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.000476	0.00252	CcSEcCtD
Epinephrine—Tension—Tretinoin—peripheral nervous system neoplasm	0.000468	0.00247	CcSEcCtD
Epinephrine—Tension—Isotretinoin—peripheral nervous system neoplasm	0.000468	0.00247	CcSEcCtD
Epinephrine—Hypokalaemia—Cisplatin—peripheral nervous system neoplasm	0.000465	0.00246	CcSEcCtD
Epinephrine—Nervousness—Isotretinoin—peripheral nervous system neoplasm	0.000463	0.00245	CcSEcCtD
Epinephrine—Nervousness—Tretinoin—peripheral nervous system neoplasm	0.000463	0.00245	CcSEcCtD
Epinephrine—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.000462	0.00244	CcSEcCtD
Epinephrine—Necrosis—Epirubicin—peripheral nervous system neoplasm	0.000461	0.00244	CcSEcCtD
Epinephrine—Acute coronary syndrome—Alitretinoin—peripheral nervous system neoplasm	0.000456	0.00241	CcSEcCtD
Epinephrine—Renal failure—Alitretinoin—peripheral nervous system neoplasm	0.000454	0.0024	CcSEcCtD
Epinephrine—Myocardial infarction—Alitretinoin—peripheral nervous system neoplasm	0.000453	0.0024	CcSEcCtD
Epinephrine—Ventricular arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.00239	CcSEcCtD
Epinephrine—Sweating—Alitretinoin—peripheral nervous system neoplasm	0.000443	0.00234	CcSEcCtD
Epinephrine—Acute coronary syndrome—Vincristine—peripheral nervous system neoplasm	0.000439	0.00232	CcSEcCtD
Epinephrine—Agitation—Tretinoin—peripheral nervous system neoplasm	0.000438	0.00232	CcSEcCtD
Epinephrine—Agitation—Isotretinoin—peripheral nervous system neoplasm	0.000438	0.00232	CcSEcCtD
Epinephrine—Myocardial infarction—Vincristine—peripheral nervous system neoplasm	0.000436	0.00231	CcSEcCtD
Epinephrine—Sweating increased—Cisplatin—peripheral nervous system neoplasm	0.00043	0.00227	CcSEcCtD
Epinephrine—Sweating—Vincristine—peripheral nervous system neoplasm	0.000427	0.00226	CcSEcCtD
Epinephrine—Necrosis—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.00225	CcSEcCtD
Epinephrine—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.000421	0.00223	CcSEcCtD
Epinephrine—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.000421	0.00223	CcSEcCtD
Epinephrine—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.000417	0.00221	CcSEcCtD
Epinephrine—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.000415	0.0022	CcSEcCtD
Epinephrine—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.000415	0.00219	CcSEcCtD
Epinephrine—Extravasation—Epirubicin—peripheral nervous system neoplasm	0.000414	0.00219	CcSEcCtD
Epinephrine—Hypoaesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000413	0.00218	CcSEcCtD
Epinephrine—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.000413	0.00218	CcSEcCtD
Epinephrine—Hypertension—Tretinoin—peripheral nervous system neoplasm	0.000411	0.00218	CcSEcCtD
Epinephrine—Hypertension—Isotretinoin—peripheral nervous system neoplasm	0.000411	0.00218	CcSEcCtD
Epinephrine—Chest pain—Topotecan—peripheral nervous system neoplasm	0.000409	0.00216	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000406	0.00215	CcSEcCtD
Epinephrine—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.000406	0.00215	CcSEcCtD
Epinephrine—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.000406	0.00215	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000403	0.00213	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000403	0.00213	CcSEcCtD
Epinephrine—Chest pain—Melphalan—peripheral nervous system neoplasm	0.0004	0.00212	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Epirubicin—peripheral nervous system neoplasm	0.0004	0.00212	CcSEcCtD
Epinephrine—Hypoaesthesia—Vincristine—peripheral nervous system neoplasm	0.000398	0.0021	CcSEcCtD
Epinephrine—Hallucination—Vincristine—peripheral nervous system neoplasm	0.000398	0.0021	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000398	0.0021	CcSEcCtD
Epinephrine—Sweating increased—Etoposide—peripheral nervous system neoplasm	0.000394	0.00208	CcSEcCtD
Epinephrine—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.000389	0.00206	CcSEcCtD
Epinephrine—Acute coronary syndrome—Cisplatin—peripheral nervous system neoplasm	0.000388	0.00205	CcSEcCtD
Epinephrine—Renal failure—Cisplatin—peripheral nervous system neoplasm	0.000387	0.00205	CcSEcCtD
Epinephrine—Myocardial infarction—Cisplatin—peripheral nervous system neoplasm	0.000386	0.00204	CcSEcCtD
Epinephrine—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.000385	0.00204	CcSEcCtD
Epinephrine—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.000384	0.00203	CcSEcCtD
Epinephrine—Extravasation—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.00203	CcSEcCtD
Epinephrine—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000381	0.00202	CcSEcCtD
Epinephrine—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000381	0.00202	CcSEcCtD
Epinephrine—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000381	0.00201	CcSEcCtD
Epinephrine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.00038	0.00201	CcSEcCtD
Epinephrine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.00038	0.00201	CcSEcCtD
Epinephrine—Hyperhidrosis—Topotecan—peripheral nervous system neoplasm	0.000379	0.002	CcSEcCtD
Epinephrine—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000378	0.002	CcSEcCtD
Epinephrine—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000378	0.002	CcSEcCtD
Epinephrine—Hyperhidrosis—Tretinoin—peripheral nervous system neoplasm	0.000376	0.00199	CcSEcCtD
Epinephrine—Hyperhidrosis—Isotretinoin—peripheral nervous system neoplasm	0.000376	0.00199	CcSEcCtD
Epinephrine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000375	0.00198	CcSEcCtD
Epinephrine—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000373	0.00197	CcSEcCtD
Epinephrine—Arrhythmia—Alitretinoin—peripheral nervous system neoplasm	0.000371	0.00196	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Doxorubicin—peripheral nervous system neoplasm	0.00037	0.00196	CcSEcCtD
Epinephrine—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.000363	0.00192	CcSEcCtD
Epinephrine—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.000361	0.00191	CcSEcCtD
Epinephrine—Acute coronary syndrome—Etoposide—peripheral nervous system neoplasm	0.000356	0.00188	CcSEcCtD
Epinephrine—Renal failure—Etoposide—peripheral nervous system neoplasm	0.000355	0.00188	CcSEcCtD
Epinephrine—Tension—Alitretinoin—peripheral nervous system neoplasm	0.000354	0.00187	CcSEcCtD
Epinephrine—Myocardial infarction—Etoposide—peripheral nervous system neoplasm	0.000354	0.00187	CcSEcCtD
Epinephrine—Paraesthesia—Topotecan—peripheral nervous system neoplasm	0.000352	0.00186	CcSEcCtD
Epinephrine—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000352	0.00186	CcSEcCtD
Epinephrine—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000352	0.00186	CcSEcCtD
Epinephrine—Nervousness—Alitretinoin—peripheral nervous system neoplasm	0.000351	0.00185	CcSEcCtD
Epinephrine—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.00035	0.00185	CcSEcCtD
Epinephrine—Paraesthesia—Tretinoin—peripheral nervous system neoplasm	0.000349	0.00185	CcSEcCtD
Epinephrine—Paraesthesia—Isotretinoin—peripheral nervous system neoplasm	0.000349	0.00185	CcSEcCtD
Epinephrine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.000346	0.00183	CcSEcCtD
Epinephrine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.000346	0.00183	CcSEcCtD
Epinephrine—Skin exfoliation—Epirubicin—peripheral nervous system neoplasm	0.000345	0.00183	CcSEcCtD
Epinephrine—Paraesthesia—Melphalan—peripheral nervous system neoplasm	0.000345	0.00182	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000338	0.00179	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000336	0.00178	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000336	0.00178	CcSEcCtD
Epinephrine—Agitation—Alitretinoin—peripheral nervous system neoplasm	0.000332	0.00176	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000331	0.00175	CcSEcCtD
Epinephrine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000328	0.00173	CcSEcCtD
Epinephrine—Hypoaesthesia—Etoposide—peripheral nervous system neoplasm	0.000322	0.0017	CcSEcCtD
Epinephrine—Pulmonary oedema—Epirubicin—peripheral nervous system neoplasm	0.000322	0.0017	CcSEcCtD
Epinephrine—Agitation—Vincristine—peripheral nervous system neoplasm	0.00032	0.00169	CcSEcCtD
Epinephrine—Skin exfoliation—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.00169	CcSEcCtD
Epinephrine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000319	0.00169	CcSEcCtD
Epinephrine—Arrhythmia—Cisplatin—peripheral nervous system neoplasm	0.000316	0.00167	CcSEcCtD
Epinephrine—Hypertension—Alitretinoin—peripheral nervous system neoplasm	0.000312	0.00165	CcSEcCtD
Epinephrine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000308	0.00163	CcSEcCtD
Epinephrine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000307	0.00163	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000305	0.00161	CcSEcCtD
Epinephrine—Flushing—Etoposide—peripheral nervous system neoplasm	0.000301	0.00159	CcSEcCtD
Epinephrine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.0003	0.00159	CcSEcCtD
Epinephrine—Pulmonary oedema—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.00157	CcSEcCtD
Epinephrine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000289	0.00153	CcSEcCtD
Epinephrine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000288	0.00152	CcSEcCtD
Epinephrine—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000286	0.00151	CcSEcCtD
Epinephrine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000285	0.00151	CcSEcCtD
Epinephrine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000278	0.00147	CcSEcCtD
Epinephrine—Renal impairment—Epirubicin—peripheral nervous system neoplasm	0.000276	0.00146	CcSEcCtD
Epinephrine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000275	0.00145	CcSEcCtD
Epinephrine—Hypoglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000269	0.00142	CcSEcCtD
Epinephrine—Cerebrovascular accident—Epirubicin—peripheral nervous system neoplasm	0.000268	0.00142	CcSEcCtD
Epinephrine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.00141	CcSEcCtD
Epinephrine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000265	0.0014	CcSEcCtD
Epinephrine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000262	0.00139	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.00026	0.00138	CcSEcCtD
Epinephrine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000259	0.00137	CcSEcCtD
Epinephrine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000257	0.00136	CcSEcCtD
Epinephrine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000257	0.00136	CcSEcCtD
Epinephrine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000257	0.00136	CcSEcCtD
Epinephrine—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.00135	CcSEcCtD
Epinephrine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000255	0.00135	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000254	0.00135	CcSEcCtD
Epinephrine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000249	0.00132	CcSEcCtD
Epinephrine—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000249	0.00132	CcSEcCtD
Epinephrine—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000248	0.00131	CcSEcCtD
Epinephrine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000247	0.00131	CcSEcCtD
Epinephrine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000247	0.00131	CcSEcCtD
Epinephrine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000246	0.0013	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000245	0.0013	CcSEcCtD
Epinephrine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000245	0.0013	CcSEcCtD
Epinephrine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000244	0.00129	CcSEcCtD
Epinephrine—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000244	0.00129	CcSEcCtD
Epinephrine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000243	0.00129	CcSEcCtD
Epinephrine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000243	0.00128	CcSEcCtD
Epinephrine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00024	0.00127	CcSEcCtD
Epinephrine—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000239	0.00126	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000238	0.00126	CcSEcCtD
Epinephrine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000233	0.00123	CcSEcCtD
Epinephrine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000231	0.00122	CcSEcCtD
Epinephrine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000231	0.00122	CcSEcCtD
Epinephrine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000228	0.00121	CcSEcCtD
Epinephrine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000225	0.00119	CcSEcCtD
Epinephrine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000225	0.00119	CcSEcCtD
Epinephrine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000223	0.00118	CcSEcCtD
Epinephrine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000222	0.00118	CcSEcCtD
Epinephrine—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.00117	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000217	0.00115	CcSEcCtD
Epinephrine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000207	0.00109	CcSEcCtD
Epinephrine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00108	CcSEcCtD
Epinephrine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000205	0.00108	CcSEcCtD
Epinephrine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000202	0.00107	CcSEcCtD
Epinephrine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000202	0.00107	CcSEcCtD
Epinephrine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000199	0.00105	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000199	0.00105	CcSEcCtD
Epinephrine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000195	0.00103	CcSEcCtD
Epinephrine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000194	0.00103	CcSEcCtD
Epinephrine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.001	CcSEcCtD
Epinephrine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000189	0.000999	CcSEcCtD
Epinephrine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000188	0.000993	CcSEcCtD
Epinephrine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.000991	CcSEcCtD
Epinephrine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000989	CcSEcCtD
Epinephrine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000973	CcSEcCtD
Epinephrine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000965	CcSEcCtD
Epinephrine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000182	0.00096	CcSEcCtD
Epinephrine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000955	CcSEcCtD
Epinephrine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000181	0.000955	CcSEcCtD
Epinephrine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000949	CcSEcCtD
Epinephrine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000175	0.000926	CcSEcCtD
Epinephrine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000893	CcSEcCtD
Epinephrine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000169	0.000892	CcSEcCtD
Epinephrine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000891	CcSEcCtD
Epinephrine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000888	CcSEcCtD
Epinephrine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000884	CcSEcCtD
Epinephrine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000858	CcSEcCtD
Epinephrine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00016	0.000844	CcSEcCtD
Epinephrine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000841	CcSEcCtD
Epinephrine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000836	CcSEcCtD
Epinephrine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000824	CcSEcCtD
Epinephrine—Tension—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00082	CcSEcCtD
Epinephrine—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000812	CcSEcCtD
Epinephrine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000152	0.000805	CcSEcCtD
Epinephrine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000793	CcSEcCtD
Epinephrine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000789	CcSEcCtD
Epinephrine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000778	CcSEcCtD
Epinephrine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000146	0.000774	CcSEcCtD
Epinephrine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000773	CcSEcCtD
Epinephrine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000768	CcSEcCtD
Epinephrine—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000759	CcSEcCtD
Epinephrine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000751	CcSEcCtD
Epinephrine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000738	CcSEcCtD
Epinephrine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000137	0.000723	CcSEcCtD
Epinephrine—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000721	CcSEcCtD
Epinephrine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000711	CcSEcCtD
Epinephrine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000711	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000707	CcSEcCtD
Epinephrine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000683	CcSEcCtD
Epinephrine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000669	CcSEcCtD
Epinephrine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000668	CcSEcCtD
Epinephrine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000666	CcSEcCtD
Epinephrine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000662	CcSEcCtD
Epinephrine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000659	CcSEcCtD
Epinephrine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000658	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000654	CcSEcCtD
Epinephrine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000619	CcSEcCtD
Epinephrine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000617	CcSEcCtD
Epinephrine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000616	CcSEcCtD
Epinephrine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000613	CcSEcCtD
Epinephrine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000612	CcSEcCtD
Epinephrine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00061	CcSEcCtD
Epinephrine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000606	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000589	CcSEcCtD
Epinephrine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000571	CcSEcCtD
Epinephrine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000567	CcSEcCtD
Epinephrine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000561	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000545	CcSEcCtD
Epinephrine—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.53e-05	0.000451	CcSEcCtD
Epinephrine—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000434	CcSEcCtD
Epinephrine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.89e-05	0.000417	CcSEcCtD
Epinephrine—Nausea—Epirubicin—peripheral nervous system neoplasm	7.66e-05	0.000405	CcSEcCtD
Epinephrine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.59e-05	0.000401	CcSEcCtD
Epinephrine—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.09e-05	0.000375	CcSEcCtD
Epinephrine—ADRA1D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.31e-05	0.000275	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.3e-05	0.000273	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.29e-05	0.000273	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.29e-05	0.000272	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.28e-05	0.000272	CbGpPWpGaD
Epinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	2.28e-05	0.000271	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—BCHE—peripheral nervous system neoplasm	2.27e-05	0.00027	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.27e-05	0.00027	CbGpPWpGaD
Epinephrine—PAH—Disease—HRAS—peripheral nervous system neoplasm	2.26e-05	0.00027	CbGpPWpGaD
Epinephrine—ADRA2C—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.25e-05	0.000268	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	2.23e-05	0.000266	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.23e-05	0.000265	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.21e-05	0.000263	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	2.19e-05	0.000261	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—ENO2—peripheral nervous system neoplasm	2.18e-05	0.00026	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	2.18e-05	0.000259	CbGpPWpGaD
Epinephrine—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	2.17e-05	0.000259	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.17e-05	0.000258	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.16e-05	0.000257	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	2.15e-05	0.000256	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—NRAS—peripheral nervous system neoplasm	2.14e-05	0.000254	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—TH—peripheral nervous system neoplasm	2.13e-05	0.000254	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.12e-05	0.000253	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.11e-05	0.000251	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.1e-05	0.000251	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.09e-05	0.000248	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.08e-05	0.000247	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.06e-05	0.000245	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	2.05e-05	0.000244	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.03e-05	0.000242	CbGpPWpGaD
Epinephrine—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	2.03e-05	0.000241	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2e-05	0.000239	CbGpPWpGaD
Epinephrine—PAH—Disease—AKT1—peripheral nervous system neoplasm	2e-05	0.000238	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.99e-05	0.000237	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.98e-05	0.000235	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—NRAS—peripheral nervous system neoplasm	1.97e-05	0.000235	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.95e-05	0.000232	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—NRAS—peripheral nervous system neoplasm	1.92e-05	0.000229	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.92e-05	0.000228	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.91e-05	0.000227	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.88e-05	0.000224	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.88e-05	0.000223	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.85e-05	0.000221	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—BCHE—peripheral nervous system neoplasm	1.84e-05	0.00022	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.84e-05	0.00022	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—MYC—peripheral nervous system neoplasm	1.84e-05	0.000219	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.84e-05	0.000219	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.84e-05	0.000219	CbGpPWpGaD
Epinephrine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.83e-05	0.000218	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.81e-05	0.000216	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.81e-05	0.000216	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.8e-05	0.000214	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—NRAS—peripheral nervous system neoplasm	1.8e-05	0.000214	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.79e-05	0.000213	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.78e-05	0.000212	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.76e-05	0.00021	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.76e-05	0.00021	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.76e-05	0.000209	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—GNAS—peripheral nervous system neoplasm	1.74e-05	0.000208	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—TH—peripheral nervous system neoplasm	1.73e-05	0.000206	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.73e-05	0.000206	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.72e-05	0.000204	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.72e-05	0.000204	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.71e-05	0.000204	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—ABCB1—peripheral nervous system neoplasm	1.71e-05	0.000204	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.71e-05	0.000204	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.7e-05	0.000203	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.7e-05	0.000202	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.69e-05	0.000201	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.68e-05	0.0002	CbGpPWpGaD
Epinephrine—PAH—Metabolism—AKT1—peripheral nervous system neoplasm	1.67e-05	0.000199	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.67e-05	0.000199	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.67e-05	0.000198	CbGpPWpGaD
Epinephrine—ADRBK1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.66e-05	0.000198	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.65e-05	0.000196	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.64e-05	0.000195	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.64e-05	0.000195	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.59e-05	0.000189	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.58e-05	0.000188	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.57e-05	0.000187	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.56e-05	0.000186	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—HRAS—peripheral nervous system neoplasm	1.56e-05	0.000186	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.56e-05	0.000186	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.54e-05	0.000183	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.53e-05	0.000183	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.52e-05	0.00018	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.51e-05	0.00018	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.5e-05	0.000178	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.47e-05	0.000175	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	1.47e-05	0.000175	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	1.46e-05	0.000174	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.46e-05	0.000174	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.46e-05	0.000173	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.46e-05	0.000173	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—HRAS—peripheral nervous system neoplasm	1.44e-05	0.000172	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.43e-05	0.000171	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.42e-05	0.000169	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	1.42e-05	0.000169	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	1.41e-05	0.000168	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	1.41e-05	0.000168	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.39e-05	0.000166	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	1.39e-05	0.000165	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.39e-05	0.000165	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.38e-05	0.000164	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—AKT1—peripheral nervous system neoplasm	1.38e-05	0.000164	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—TP53—peripheral nervous system neoplasm	1.37e-05	0.000164	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.37e-05	0.000163	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.35e-05	0.000161	CbGpPWpGaD
Epinephrine—ADRB3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.33e-05	0.000159	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.32e-05	0.000157	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	1.31e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.29e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.29e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.27e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—AKT1—peripheral nervous system neoplasm	1.27e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	1.24e-05	0.000148	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.22e-05	0.000146	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.21e-05	0.000144	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.2e-05	0.000143	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.2e-05	0.000143	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	1.19e-05	0.000142	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.18e-05	0.000141	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	1.16e-05	0.000138	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.14e-05	0.000135	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	1.12e-05	0.000133	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	1.12e-05	0.000133	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.11e-05	0.000133	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.11e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.1e-05	0.000131	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.09e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.09e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.08e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.07e-05	0.000127	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.07e-05	0.000127	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.06e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.03e-05	0.000123	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.03e-05	0.000123	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.02e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.01e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.01e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.01e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	9.97e-06	0.000119	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.71e-06	0.000116	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	9.57e-06	0.000114	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	9.49e-06	0.000113	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	9.42e-06	0.000112	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	9.3e-06	0.000111	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	9.14e-06	0.000109	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	9.01e-06	0.000107	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	8.97e-06	0.000107	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.94e-06	0.000106	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.92e-06	0.000106	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.85e-06	0.000105	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.69e-06	0.000104	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.65e-06	0.000103	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	8.61e-06	0.000103	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.57e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.48e-06	0.000101	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.46e-06	0.000101	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.37e-06	9.97e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.22e-06	9.79e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.15e-06	9.7e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.11e-06	9.66e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.07e-06	9.61e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8e-06	9.53e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.97e-06	9.49e-05	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.92e-06	9.43e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.89e-06	9.4e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7.88e-06	9.38e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	7.86e-06	9.36e-05	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.85e-06	9.35e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.85e-06	9.35e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	7.81e-06	9.31e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.78e-06	9.26e-05	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.75e-06	9.23e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.68e-06	9.14e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	7.67e-06	9.13e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.54e-06	8.98e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.49e-06	8.93e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	7.42e-06	8.84e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	7.39e-06	8.8e-05	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.33e-06	8.73e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.26e-06	8.65e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.22e-06	8.6e-05	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	7.22e-06	8.59e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.19e-06	8.57e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.16e-06	8.53e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.15e-06	8.51e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.13e-06	8.49e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.04e-06	8.38e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	7e-06	8.33e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.73e-06	8.01e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.66e-06	7.93e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.59e-06	7.85e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.58e-06	7.83e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	6.55e-06	7.8e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.52e-06	7.76e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.5e-06	7.74e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.43e-06	7.66e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	6.41e-06	7.63e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.35e-06	7.56e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.13e-06	7.3e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	6.12e-06	7.29e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.09e-06	7.25e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.07e-06	7.23e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	6.03e-06	7.18e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.99e-06	7.14e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.99e-06	7.14e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.96e-06	7.09e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.92e-06	7.05e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.9e-06	7.03e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.82e-06	6.93e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.67e-06	6.75e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	5.58e-06	6.65e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.52e-06	6.58e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.41e-06	6.44e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.32e-06	6.34e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.28e-06	6.29e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.03e-06	5.99e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.99e-06	5.94e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.96e-06	5.9e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.95e-06	5.89e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.92e-06	5.86e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	4.84e-06	5.76e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.81e-06	5.73e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.77e-06	5.68e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.71e-06	5.61e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	4.7e-06	5.6e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.66e-06	5.55e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.66e-06	5.55e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.61e-06	5.49e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.58e-06	5.46e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	4.51e-06	5.37e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.45e-06	5.3e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.38e-06	5.22e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.25e-06	5.06e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.21e-06	5.01e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.16e-06	4.95e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	4.07e-06	4.85e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.93e-06	4.68e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.89e-06	4.64e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.87e-06	4.61e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	3.82e-06	4.55e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.78e-06	4.51e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.62e-06	4.31e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.44e-06	4.09e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.19e-06	3.8e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	2.47e-06	2.94e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.11e-06	2.51e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.63e-06	1.94e-05	CbGpPWpGaD
